Welcome to the Richer Lab!

The Richer lab uses contemporary cell and molecular biology techniques to elucidate mechanisms of endocrine therapy resistance in women’s cancers and identify targetable proteins involved in tumor progression. 

Dr. Richer’s expertise in steroid hormone receptors in cancer spans over 25 years. She has been Associate Editor for Breast Cancer Research and Endocrinology and  co-chaired the Keystone Symposium on Nuclear Hormone Receptors in 2016 and was  the Basic Science Chair of The Endocrine Society 2021 Annual Meeting. She has served on many grant review panels for the NIH,  DOD and private foundations. 

Training the next generation of cancer researchers is a priority for Dr. Richer and her trainees have obtained 4 NCI F31s, 2 F99/K00s, F32, K99/R00, DOD and ACS Fellowships and successfully moved into independent academic and industry positions. In 2015 she was awarded the Dean’s Mentoring Award from the University of Colorado Graduate School and the NIH Broadening Experiences in Scientific Training (BEST) Award for Faculty Sponsorship. She promotes junior faculty cancer research and collaborative investigations by serving for many years as PI of the University of Colorado Cancer Center (UCCC) American Cancer Society Institutional Research Grant and as a Co-Leader of the UCCC Tumor Host Interactions (THI) Program.